Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Perceptive Advisors
Biotech
Endeavor nabs $101M for IPF, cancer trials—and asset shopping
Endeavor will use $101M in attempt to beat two idiopathic pulmonary fibrosis drugs from Roche and Boehringer that have been on the market since 2014.
Kyle LaHucik
Feb 7, 2022 8:00am
Mystery revealed: Mythic lands $103M to take on ADC class
Dec 16, 2021 10:30am
Amicus spins off gene therapy unit in $600M SPAC deal
Sep 29, 2021 8:35am
Takeda norovirus vaccine spinout HilleVax snags $135M crossover
Sep 8, 2021 10:25am
Portable test maker Cue Health nets $235M for a post-COVID world
May 13, 2021 1:20pm
Perceptive unveils $515M fund, its 2nd for early-stage biotechs
May 12, 2021 6:55am